We synthesized a potent and selective antagonist radioligand for the neurokinin (NK)‐1 receptor and characterized its binding to guinea pig striatal membranes. (R) ‐ N ‐ [2 ‐ [Acetyl[3H3][(2 ‐ methoxyphenyl) ‐ methyl]amino] ‐ 1 ‐ (1H ‐ indol ‐ 3 ‐ ylmethyl)ethyl][1,4′ ‐ bipiperidine]‐1′‐acetamide ([3H]LY303870) binds to a single class of sites with an equilibrium KD of 0.22 nM and a Bmax of 723 fmol/mg of protein. Unlabeled LY303870 potently inhibited the binding with an IC50 of 0.56 nM, whereas the less active (S)‐enantiomer (LY306155) was substantially less potent. The nonpeptide NK‐1 antagonists (±)‐CP96,345 and (±)‐RP 67580 had IC50 values of 0.74 and 49 nM, respectively. Substance P (SP) was also a potent inhibitor with with an IC50 of 3.1 nM. The inhibition by SP could be separated into two components: a high‐affinity component with a Ki of 0.53 nM and a lower‐affinity component with a Ki of 155 nM. Addition of 100 µM guanylyl 5′‐imidodiphosphate [Gpp(NH)p] in the incubation increased the relative amount of the low‐affinity agonist state of the receptor. Consistent with the antagonist properties of LY303870, the dissociation rate of [3H]LY303870 was not changed by the presence of 100 µM Gpp(NH)p. The distribution of [3H]LY303870 binding sites in the guinea pig brain closely matched the distribution of NK‐1 receptors labeled by [3H]SP. Therefore, [3H]LY303870 is a potent and selective antagonist radioligand for NK‐1 receptors in guinea pig brain. In addition, regulation of NK‐1 agonist affinity by guanine nucleotides is similar to that seen for monoaminergic receptors.